TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Cand Pharm C. Cristoffersen AS
Closing information (x1000 NOK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
238,729
|
215,298
|
208,603 |
| Financial expenses |
61
|
173
|
499 |
| Earnings before taxes |
23,783
|
29,612
|
22,478 |
| Total assets |
126,988
|
114,664
|
98,625 |
| Current assets |
114,659
|
101,343
|
81,648 |
| Current liabilities |
39,153
|
39,425
|
33,502 |
| Equity capital |
87,835
|
75,239
|
65,123 |
| - share capital |
2,500
|
2,500
|
2,500 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
69.2%
|
65.6%
|
66.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.0%
|
13.8%
|
10.8% |
| Return on assets (ROA) |
18.8%
|
26.0%
|
23.3% |
| Current ratio |
292.8%
|
257.1%
|
243.7% |
| Return on equity (ROE) |
27.1%
|
39.4%
|
34.5% |
| Change turnover |
23,431
|
6,695
|
27,498 |
| Change turnover % |
11%
|
3%
|
15% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.